Proteomics in Uremia and Renal Disease

被引:18
|
作者
Mischak, Harald [1 ]
Massy, Ziad A. [2 ,3 ]
Jankowski, Joachim [4 ]
机构
[1] Mosaiques Diagnost & Therapeut AG, D-30625 Hannover, Germany
[2] Univ Picardie, INSERM, ERI 12, Amiens, France
[3] Amiens Univ Hosp, Amiens, France
[4] Charite, Med Klin CBF 4, D-13353 Berlin, Germany
关键词
ENHANCED LASER-DESORPTION/IONIZATION; MASS-SPECTROMETRY; BIOMARKER DISCOVERY; CAPILLARY-ELECTROPHORESIS; URINARY PROTEOME; DIABETIC-NEPHROPATHY; CLINICAL PROTEOMICS; PROSTATE-CANCER; PLASMA PROTEOME; IDENTIFICATION;
D O I
10.1111/j.1525-139X.2009.00591.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Proteomics has emerged as a powerful technology to decipher biological processes. One of the main goals of proteomics is the identification of biomarkers for diseases from tissues and body fluids. However, the complexity and wide dynamic range of protein expression presents an enormous challenge. This review gives an overview of the different technologies used, their potentials and limitations, focusing on capillary electrophoresis coupled to mass spectrometry (CE-MS). CE-MS is discussed from an application point of view, evaluating its merits and vices for biomarker discovery and clinical applications in chronic kidney disease. Finally, several examples on the application of CE-MS to determine biomarkers for disease diagnosis, prognosis, and therapy evaluation are presented.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 50 条
  • [1] COMPLICATIONS IN TREATMENT OF CHRONIC UREMIA IN POLYCYSTIC RENAL DISEASE
    HERRERAP.J
    OCONPUJA.J
    MARINIRA.R
    REVISTA CLINICA ESPANOLA, 1974, 132 (05): : 415 - 422
  • [2] Urine Proteomics and Biomarkers in Renal Disease
    Kim, Min Jeong
    Frankel, Andrew H.
    Tam, Frederick W. K.
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2011, 119 (01): : E1 - E7
  • [3] Is there a role for proteomics in diabetic renal disease?
    Currie, Gemma
    Mary, Sheon
    Delles, Christian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (07) : 1133 - 1135
  • [4] Free Radicals in Uremia and End-Stage Renal Disease
    Cohen, Burton D.
    DIALYSIS & TRANSPLANTATION, 2010, 39 (04) : 138 - 140
  • [5] Glomerular protein trafficking and progression of renal disease to terminal uremia
    Benigni, A
    Remuzzi, G
    SEMINARS IN NEPHROLOGY, 1996, 16 (03) : 151 - 159
  • [6] HEMORRHAGIC DIATHESIS IN RENAL DISEASE - (WITH SPECIAL REFERENCE TO ACUTE UREMIA)
    KENDALL, AG
    LOWENSTEIN, L
    MORGEN, RO
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1961, 85 (08) : 405 - &
  • [7] Towards the application of proteomics in renal disease diagnosis
    Vidal, BC
    Bonventre, JV
    Hsu, SIH
    CLINICAL SCIENCE, 2005, 109 (05) : 421 - 430
  • [8] ON RENAL CRYSTALS IN UREMIA
    BOSMAN, C
    LAGINEST.A
    NEPHRON, 1967, 4 (03): : 173 - &
  • [9] Timing of initiation of uremia therapy and survival in patients with progressive renal disease
    Ifudu, O
    Dawood, M
    Homel, P
    Friedman, EA
    AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (03) : 193 - 198
  • [10] CHRONIC UREMIA DUE TO POLYCYSTIC RENAL DISEASE TREATED WITH THE ARTIFICIAL KIDNEY
    NAKAMOTO, S
    KOLFF, WJ
    ARCHIVES OF INTERNAL MEDICINE, 1958, 101 (05) : 921 - 926